NTP
MLAB icon

Nine Ten Partners’s Mesa Laboratories MLAB Stock Holding History

Nine Ten Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$16M Buy
+207,460
New +$15.2M 5.22% 9

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Nine Ten Partners's MLAB Position: Q4 2014 in Review

Nine Ten Partners opened a new position in Mesa Laboratories (MLAB) in Q4 2014: 207,460 shares worth $16M. The stake represents 5.22% of the portfolio and ranks #9 among its holdings.

60 funds tracked by Wall St. Rank hold MLAB as of Q4 2014.

  • Nine Ten Partners held 207,460 shares of Mesa Laboratories worth $16M as of Q4 2014.
  • Mesa Laboratories was a new Nine Ten Partners position in Q4 2014.
  • Mesa Laboratories made up 5.22% of Nine Ten Partners's portfolio in Q4 2014, its #9 holding.
  • 60 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2014.

Based on Nine Ten Partners's 13F filing for Q4 2014, filed 17 Feb 2015.